Literature DB >> 1851524

Characterization of the gene and messages for vasoactive intestinal polypeptide (VIP) in rat and mouse.

E D Lamperti1, K M Rosen, L Villa-Komaroff.   

Abstract

We have studied the structure and expression of the gene for vasoactive intestinal polypeptide (VIP) in rodents. We used a human cDNA to identify and clone a fragment of the rat VIP gene. This genomic fragment contained two separate exons, one encoding VIP itself and the other encoding a closely related neuropeptide, peptide histidine-isoleucine (PHI-27). Probes containing either exon, or both, hybridized to two messages: a prominent 1700-base (b) mRNA and a rare 1000-b species. These messages are expressed together in a tissue-specific manner, with highest levels in polyadenylated RNA from cerebral cortex and from small intestine, paralleling the reported levels of the neuropeptides themselves in these tissues. Using the rat genomic fragment as a probe, we isolated the mouse VIP gene in its entirety. The mouse gene is similar in organization to its human counterpart, with a total of 7 exons spanning 8 kilobases (kb). The 7th and largest exon, which is transcribed into the bulk of the 3' untranslated region of the messages, bears two potential polyadenylation sites 700 basepairs (bp) apart. S-1 nuclease protection with a fragment of this exon indicated that the two identifiable VIP messages differ in the extent of their 3' untranslated regions. Conversely, we found no evidence for differential splicing to produce messages encoding only one of the neuropeptides. Instead, specific oligonucleotide-directed digestion with RNase H demonstrated that all of the detectable mRNA from this gene contains both VIP and PHI coding sequences.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1851524     DOI: 10.1016/0169-328x(91)90005-i

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  8 in total

1.  Corruption of genomic databases with anomalous sequence.

Authors:  E D Lamperti; J M Kittelberger; T F Smith; L Villa-Komaroff
Journal:  Nucleic Acids Res       Date:  1992-06-11       Impact factor: 16.971

2.  Vasoactive intestinal peptide signaling axis in human leukemia.

Authors:  Glenn Paul Dorsam; Keith Benton; Jarrett Failing; Sandeep Batra
Journal:  World J Biol Chem       Date:  2011-06-26

3.  Effect of human vasoactive intestinal peptide gene transfer in a murine model of Sjogren's syndrome.

Authors:  B M Lodde; F Mineshiba; J Wang; A P Cotrim; S Afione; P P Tak; B J Baum
Journal:  Ann Rheum Dis       Date:  2005-06-23       Impact factor: 19.103

4.  Learning and sexual deficiencies in transgenic mice carrying a chimeric vasoactive intestinal peptide gene.

Authors:  I Gozes; J Glowa; D E Brenneman; S K McCune; E Lee; H Westphal
Journal:  J Mol Neurosci       Date:  1993       Impact factor: 3.444

5.  Expression of mRNA for vasoactive intestinal peptide in normal human colon and during inflammation.

Authors:  A Schulte-Bockholt; J G Fink; D A Meier; M F Otterson; G L Telford; K Hopp; T R Koch
Journal:  Mol Cell Biochem       Date:  1995-01-12       Impact factor: 3.396

6.  Phenotypic plasticity in adult sympathetic neurons: changes in neuropeptide expression in organ culture.

Authors:  R E Zigmond; H Hyatt-Sachs; C Baldwin; X M Qu; Y Sun; T W McKeon; R C Schreiber; U Vaidyanathan
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-15       Impact factor: 11.205

7.  Characterization of an enhancer region of the galanin gene that directs expression to the dorsal root ganglion and confers responsiveness to axotomy.

Authors:  Andrea Bacon; Niall C H Kerr; Fiona E Holmes; Kevin Gaston; David Wynick
Journal:  J Neurosci       Date:  2007-06-13       Impact factor: 6.167

Review 8.  VIP/PACAP signaling as an alternative target during hyperoxic exposure in preterm newborns.

Authors:  Q Thaçi; S Reçica; I Kryeziu; V Mitrokhin; A Kamkin; R Sopi; N Hadzi-Petrushev; M Mladenov
Journal:  Physiol Res       Date:  2021-06-01       Impact factor: 1.881

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.